Bluezone, an insurtech reinventing life insurance for people with chronic illnesses, launches in the UK with a unique policy for people with Type 2 diabetes.
The new life insurance solution offers any individuals in the UK with Type 2 diabetes life insurance cover through a seamless digital journey that will deliver a 10-fold improvement on the current solution by removing lengthy form filling and required medical appointments previously needed to secure a similar policy.
The product comes at a critical time as there are currently over 4 million people diagnosed with Type 2 diabetes in the UK and almost 1 million more people living with the chronic illness, who don’t know they have it. The UK ranks among the worst in Europe with the most overweight and obese adults, according to the World Health Organization. In the last five years, there has been an alarming acceleration in the number of people diagnosed with the illness with the amount diagnosed increasing by 18%.
Bluezone will be working with leading insurer Covéa Life and global reinsurer Gen Re to facilitate the new and unique life insurance policy. This is the first of a portfolio of policies the firm is planning to launch to help individuals with other chronic health conditions both in the UK and overseas. Traditional underwriting processes were outdated, manual and cumbersome making it difficult for individuals with these chronic conditions to access affordable insurance but the new Type 2 diabetes policy will start to change access to cover for millions of individuals.
Dr Karan Mehta, Co-Founder & CEO, Bluezone Insurance said, “We are delighted to announce the launch of our first life insurance policy and to be able to help individuals with Type 2 diabetes to gain cover. The launch is the culmination of a huge amount of hard work from the Bluezone team along with the support from our investors and partners.
I would also like to thank the teams at Gen Re and Covéa Life for their ongoing support and belief in the proposition which has allowed us to launch our game-changing proposition.”